CN104771627B - A kind of Chinese medicine composition for treating the prolapse of uterus - Google Patents
A kind of Chinese medicine composition for treating the prolapse of uterus Download PDFInfo
- Publication number
- CN104771627B CN104771627B CN201510160006.XA CN201510160006A CN104771627B CN 104771627 B CN104771627 B CN 104771627B CN 201510160006 A CN201510160006 A CN 201510160006A CN 104771627 B CN104771627 B CN 104771627B
- Authority
- CN
- China
- Prior art keywords
- parts
- prolapse
- uterus
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 208000012287 Prolapse Diseases 0.000 title claims abstract description 20
- 210000004291 uterus Anatomy 0.000 title claims abstract description 18
- 239000003292 glue Substances 0.000 claims abstract description 15
- 241000282994 Cervidae Species 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 241001278833 Rosa laevigata Species 0.000 claims abstract 7
- 235000000661 Rosa laevigata Nutrition 0.000 claims abstract 7
- 239000000463 material Substances 0.000 claims abstract 7
- 210000002826 placenta Anatomy 0.000 claims abstract 7
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- -1 pulvis Substances 0.000 claims 1
- 235000014347 soups Nutrition 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000002269 spontaneous effect Effects 0.000 abstract description 2
- 230000035900 sweating Effects 0.000 abstract description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 10
- 241000238413 Octopus Species 0.000 description 9
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 8
- 235000017491 Bambusa tulda Nutrition 0.000 description 8
- 241001330002 Bambuseae Species 0.000 description 8
- 244000025254 Cannabis sativa Species 0.000 description 8
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 8
- 235000006533 astragalus Nutrition 0.000 description 8
- 239000011425 bamboo Substances 0.000 description 8
- 241001061264 Astragalus Species 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000004233 talus Anatomy 0.000 description 7
- 241000206501 Actaea <angiosperm> Species 0.000 description 6
- 241000207199 Citrus Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000003056 antler Anatomy 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000512259 Ascophyllum nodosum Species 0.000 description 3
- 241000167854 Bourreria succulenta Species 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 206010041497 Spermatorrhoea Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000003679 cervix uteri Anatomy 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000003903 pelvic floor Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000009120 supportive therapy Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241000209128 Bambusa Species 0.000 description 1
- 206010006322 Breath holding Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000205571 Caulophyllum Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036872 Prolonged labour Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及医药领域,特别是一种治疗子宫脱垂的中药组合物。The invention relates to the field of medicine, in particular to a traditional Chinese medicine composition for treating uterine prolapse.
背景技术Background technique
子宫脱垂,祖国医学称之为阴挺、阴脱等。病因多为产育过多,分娩时产程长,用力过度或处理不当,损伤胞络;或产后过早参加重体力劳动,过久站立与蹲位;或体质虚弱,长期咳嗽、便秘、腹泻等导致腹压增高,使盆底肌肉及筋膜过度伸展或损伤。患者因劳倦、多产,损伤脾肾,脾气不足则中气下陷,肾气亏损致带脉失约,冲任不固,无力维系胞宫,子宫韧带松弛,子宫失去悬吊而发本病。西医治疗以支持疗法、子宫托或手术治疗为主,临床疗效不明显。因此,治疗子宫脱垂药物上的改进和创新是目前亟需解决的问题。Uterine prolapse is referred to as Yin Ting, Yin Prolapse, etc. in traditional Chinese medicine. The cause is usually excessive birth, long labor during delivery, excessive force or improper handling, damage to the cell network; or early participation in heavy physical labor after delivery, standing and squatting for too long; or weak constitution, long-term cough, constipation, diarrhea, etc. This leads to increased abdominal pressure, which can overstretch or damage the pelvic floor muscles and fascia. The patient suffers from fatigue and prolificacy, which damages the spleen and kidneys. Insufficient spleen qi leads to subsidence of central qi, loss of kidney qi leads to loss of contraction of the meridians, failure of Chong and Ren, inability to maintain the uterus, relaxation of uterine ligaments, and loss of suspension of the uterus. Western medicine treatment is mainly based on supportive therapy, pessary or surgical treatment, and the clinical curative effect is not obvious. Therefore, the improvement and innovation of drugs for the treatment of uterine prolapse is an urgent problem to be solved at present.
发明内容Contents of the invention
针对上述情况,为解决现有技术之缺陷,本发明之目的就是提供一种治疗子宫脱垂的中药组合物,可有效解决子宫脱垂的用药问题。In view of the above situation, in order to solve the defects of the prior art, the object of the present invention is to provide a traditional Chinese medicine composition for treating uterine prolapse, which can effectively solve the medication problem of uterine prolapse.
本发明解决的技术方案是,由以下重量份数计的原料药物制成:竹头草10-40份、黄芪10-30份、升麻5-15份、枳壳5-15份、金樱子10-20份、海螵蛸5-15份、禹余粮10-20份、紫河车5-15份和鹿角胶5-20份。The technical scheme solved by the present invention is made from the following raw materials in parts by weight: 10-40 parts of bamboo head grass, 10-30 parts of astragalus, 5-15 parts of Cimicifuga, 5-15 parts of Fructus aurantium, 10-20 parts of kelp, 5-15 parts of octopus, 10-20 parts of Yu Yuliang, 5-15 parts of Ziheche and 5-20 parts of deer horn glue.
本发明原料丰富,价格低廉,组份科学,合理配伍,互相支持,诸药共奏补中益气升提、培元固涩之功效,有效用于治疗子宫脱垂,疗效好,用药安全,是治疗子宫脱垂药物上的一大创新。The invention has rich raw materials, low price, scientific components, reasonable compatibility and mutual support, and all the medicines have the effects of invigorating the middle, replenishing qi, improving energy, nourishing yuan and strengthening astringency, and are effectively used to treat uterine prolapse, with good curative effect and safe medication. It is a major innovation in the treatment of uterine prolapse.
具体实施方式detailed description
以下结合实施例对本发明的具体实施方式作进一步详细说明。The specific implementation of the present invention will be described in further detail below in conjunction with the examples.
实施例1Example 1
本发明在具体实施时,可由以下重量份数计的原料药物制成:竹头草10份、黄芪30份、升麻5份、枳壳15份、金樱子10份、海螵蛸15份、禹余粮10份、紫河车15份和鹿角胶5份。When the present invention is implemented, it can be prepared from the following raw materials in parts by weight: 10 parts of bamboo head grass, 30 parts of astragalus, 5 parts of Cimicifuga, 15 parts of Citrus aurantii, 10 parts of Fructus Rosa, 15 parts of sea octopus , 10 parts of Yu Yuliang, 15 parts of Ziheche and 5 parts of antler glue.
实施例2Example 2
本发明在具体实施时,还可由以下重量份数计的原料药物制成:竹头草25份、黄芪20份、升麻10份、枳壳10份、金樱子15份、海螵蛸10份、禹余粮15份、紫河车10份和鹿角胶12份。When the present invention is implemented, it can also be made from the following raw materials in parts by weight: 25 parts of bamboo head grass, 20 parts of astragalus, 10 parts of Cimicifuga, 10 parts of Citrus aurantii, 15 parts of Fructus Rosa, 10 parts of sea octopus 15 servings of Yu Yuliang, 10 servings of Ziheche and 12 servings of antler glue.
实施例3Example 3
本发明在具体实施时,还可由以下重量份数计的原料药物制成:竹头草40份、黄芪10份、升麻15份、枳壳5份、金樱子20份、海螵蛸5份、禹余粮20份、紫河车5份和鹿角胶20份。When the present invention is implemented, it can also be made from the following raw materials in parts by weight: 40 parts of bamboo head grass, 10 parts of astragalus, 15 parts of Cimicifuga, 5 parts of Citrus aurantii, 20 parts of Fructus Rosa, 5 parts of sea octopus 20 parts of Yu Yuliang, 5 parts of Ziheche and 20 parts of antler glue.
实施例4Example 4
本发明在具体实施时,还可由以下重量份数计的原料药物制成:竹头草10-25份、黄芪10-25份、升麻5-10份、枳壳5-10份、金樱子10-15份、海螵蛸5-10份、禹余粮10-15份、紫河车5-10份和鹿角胶5-12份。When the present invention is actually implemented, it can also be made from the following raw materials in parts by weight: 10-25 parts of bamboo head grass, 10-25 parts of astragalus, 5-10 parts of Cimicifuga, 5-10 parts of Fructus aurantium, and 10-15 parts of kelp, 5-10 parts of octopus, 10-15 parts of Yu Yuliang, 5-10 parts of Ziheche and 5-12 parts of deer horn glue.
实施例5Example 5
本发明在具体实施时,还可由以下重量份数计的原料药物制成:竹头草26-40份、黄芪26-30份、升麻11-15份、枳壳11-15份、金樱子16-20份、海螵蛸11-15份、禹余粮11-20份、紫河车11-15份和鹿角胶13-20份。When the present invention is actually implemented, it can also be made from the following raw materials in parts by weight: 26-40 parts of bamboo head grass, 26-30 parts of astragalus, 11-15 parts of Cimicifuga, 11-15 parts of Citrus aurantii, and golden cherry 16-20 parts of kelp, 11-15 parts of octopus, 11-20 parts of Yu Yuliang, 11-15 parts of Zihe car and 13-20 parts of deer horn glue.
本发明中药组合物可根据临床实际的需要,按常规制备方法制成汤剂、粉剂(散剂)、片剂、颗粒剂、丸剂、胶囊剂等适于应用的各种剂型,下边给出常规方法制成的汤剂,具体是:先将竹头草、黄芪、升麻、枳壳、金樱子、海螵蛸、禹余粮、紫河车和鹿角胶混合在一起,放入药罐中,加水浸没,浸泡30-60min,武火煎煮至沸腾后,改用文火煎煮20-30min,过滤,得滤液,滤渣再加水浸没,武火煎煮至沸腾后,改用文火煎煮20-30min,过滤,得滤液,合并两次滤液,混匀即成。The Chinese medicine composition of the present invention can be made into various dosage forms suitable for application such as decoction, powder (powder), tablet, granule, pill, capsule, etc. according to the actual clinical needs, and the conventional method is given below The prepared decoction is as follows: first mix bamboo head grass, astragalus, cohosh, aurantium citrus, golden cherry, sea octopus, Yu Yuliang, Ziheche and antler gum, and put it into a medicine jar. Submerge in water, soak for 30-60min, decoct with strong fire until boiling, then decoct with slow fire for 20-30min, filter to get the filtrate, add water to the filter residue, decoct with strong fire until boiling, then decoct with slow fire for 20-30min, Filtrate to obtain the filtrate, combine the two filtrates, mix well and serve.
在本发明组分中:Among the components of the present invention:
竹头草:甘、温。归脾经。益气固脱。临床用于脱肛,子宫脱垂等症。Bamboo Head Grass: sweet, warm. Return the spleen channel. Yiqi solid off. It is clinically used for prolapse of the anus and uterine prolapse.
黄芪:甘,温。归肺、脾经。补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。Radix Astragali: sweet, warm. Return lung, spleen channel. Invigorating qi and solidifying the surface, diuretic to support toxin, evacuation of pus, astringing sores and promoting granulation. For qi deficiency and fatigue, lack of appetite, loose stools, subsidence of middle qi, prolonged diarrhea and prolapse of the anus, bloody stool and metrorrhagia, surface deficiency and spontaneous sweating, qi deficiency and edema, carbuncle and gangrene that are difficult to burst, long-term ulceration, blood deficiency and jaundice, internal heat and quenching thirst; chronic nephritis Proteinuria, diabetes.
升麻:辛、微甘,微寒。归肺、脾、胃、大肠经。发表透疹,清热解毒,升举阳气。用于风热头痛,齿痛,口疮,咽喉肿痛,麻疹不透,阳毒发斑;脱肛,子宫脱垂。Radix Cimicifugae: pungent, slightly sweet, slightly cold. Return lung, spleen, stomach, large intestine channel. Release rash, clear away heat and detoxify, promote yang. For wind-heat headache, toothache, aphthous sores, sore throat, impervious measles, spotting of impotence; prolapse of the anus, prolapse of the uterus.
枳壳:苦、辛、酸,温。归脾、胃经。理气宽中,行滞消胀。用于胸胁气滞,胀满疼痛,食积不化,痰饮内停;胃下垂,脱肛,子官脱垂。Fructus Aurantii: bitter, pungent, sour, warm. Return spleen, stomach warp. Regulating qi and widening the middle, stagnation and swelling. For stagnation of qi in the chest and hypochondrium, fullness and pain, inability to dissolve food accumulation, internal stagnation of phlegm and retention; gastroptosis, prolapse of the anus, and prolapse of the uterine organs.
金樱子:酸、甘、涩,平。归肾、膀胱、大肠经。固精缩尿,涩肠止泻。用于遗精滑精,遗尿尿频,崩漏带下,久泻久痢。Fructus Rosa: sour, sweet, astringent, flat. Return kidney, bladder, large intestine channel. Strengthening essence and reducing urination, astringent intestines to relieve diarrhea. Used for nocturnal emission and spermatorrhea, enuresis and frequent urination, metrorrhagia and vaginal discharge, chronic diarrhea and dysentery.
海螵蛸:咸、涩,温。归脾、肾经。收敛止血,涩精止带,制酸,敛疮。用于胃痛吞酸,吐血衄血,崩漏便血,遗精滑精,赤白带下;溃疡病。外治损伤出血,疮多脓汁。Sea octopus: salty, astringent, warm. Return spleen, kidney channel. Astringent to stop bleeding, astringent essence to stop belt, antacid, astringent sores. For stomachache, acid regurgitation, vomiting blood and epistaxis, metrorrhagia and hematochezia, nocturnal emission and spermatorrhea, red and white discharge; ulcer disease. External treatment injury bleeding, sores with pus.
禹余粮:甘、涩,微寒。归胃、大肠经。涩肠止泻,收敛止血。用于久泻,久痢,崩漏,白带。Yu Yuliang: sweet, astringent, slightly cold. Return stomach, large intestine channel. Astringent intestinal antidiarrheal, astringent to stop bleeding. For chronic diarrhea, chronic dysentery, metrorrhagia, leucorrhea.
紫河车:甘、咸,温。归心、肺、肾经。温肾补精,益气养血。用于虚劳羸瘦,骨蒸盗汗,咳嗽气喘,食少气短,阳痿遗精,不孕少乳。Ziheche: sweet, salty, warm. Guixin, lung, kidney channel. Warming the kidney and tonifying essence, nourishing qi and blood. It is used for fatigue and emaciation, bone steaming and night sweats, cough and asthma, shortness of breath due to lack of food, impotence and nocturnal emission, infertility and less breast milk.
鹿角胶:甘、咸,温。归肾、肝经。温补肝肾,益精养血。用于阳痿滑精,腰膝酸冷,虚劳羸瘦,崩漏下血,便血尿血,阴疽肿痛。Deer horn glue: sweet, salty, warm. Return kidney, Liver Channel. Warming and nourishing liver and kidney, benefiting essence and nourishing blood. It is used for impotence and spermatorrhea, soreness and coldness of the waist and knees, fatigue and emaciation, metrorrhagia, hematuria, hematuria, and gangrene swelling and pain.
本发明治疗子宫脱垂的中药组合物是以中医学基础理论为基础,研制而成具有补中益气升提,培元固涩之功效的中药组合物。处方中黄芪、竹头草益气升提;升麻升阳;枳壳理气宽中,行滞消胀;金樱子,海螵蛸,禹余粮收敛固脱;紫河车、鹿角胶补肾填精。全方补肾固脱、益气升提,利用各位中药的综合作用治疗子宫脱垂,对人体无毒无害,疗效好,用药安全,并经临床实验得到了充分证明,有关临床实验资料如下:The traditional Chinese medicine composition for treating uterine prolapse of the present invention is developed on the basis of the basic theory of traditional Chinese medicine, and has the functions of invigorating the middle, replenishing qi, promoting and improving, and nourishing essence and strengthening astringency. In the prescription, Astragalus membranaceus and Bambusa invigorate qi and lift; Cimicifugae promotes yang; Fructus aurantium regulates qi, widens and moderates stagnation and relieves swelling; Golden cherry fruit, sea octopus, and Yu Yu grain converge and solidify; Ziheche and deer horn glue nourish kidney and fill Refined. The whole prescription nourishes the kidney and strengthens the body, nourishes the qi, and uses the comprehensive effects of various traditional Chinese medicines to treat uterine prolapse. It is non-toxic and harmless to the human body, has good curative effect, and is safe to use. It has been fully proved by clinical trials. The relevant clinical trial data are as follows:
本发明中药组合物以汤剂为例,The Chinese medicine composition of the present invention takes decoction as an example,
1、一般资料1. General information
120例患者中,随机分为治疗组和对照组。治疗组60例,年龄35~65岁,平均(48.38±12.71) 岁;孕次1~4次,平均(1.67±0.42)次;病程2~14年,平均(7.5±2.16)年;子宫脱垂Ⅰ度18例,Ⅱ度12例。对照组60例,年龄32~67岁,平均(46.12±10.89)岁;孕次1~3次,平均(1.75±0.52)次;病程2~15年,平均(8.2±2.73)年;子宫脱垂Ⅰ度17例,Ⅱ度13例。2组资料经统计学处理,在年龄、病情上差异均无显著性意义(P>0.05),具有可比性。120 patients were randomly divided into treatment group and control group. The treatment group included 60 cases, aged 35 to 65 years, with an average age of (48.38±12.71) years; the number of pregnancies was 1 to 4, with an average of (1.67±0.42) times; the course of disease was 2 to 14 years, with an average of (7.5±2.16) years; uterine prolapse There were 18 cases with degree I and 12 cases with degree II. 60 cases in the control group, aged 32 to 67 years, with an average of (46.12±10.89) years; pregnancy times 1 to 3, with an average of (1.75±0.52) times; course of disease 2 to 15 years, with an average of (8.2±2.73) years; uterine prolapse There were 17 cases with degree I and 13 cases with degree II. The data of the two groups were statistically processed, and there was no significant difference in age and condition (P>0.05), which were comparable.
2、病例纳入标准2. Case inclusion criteria
入选患者均为首次发病,且未经正规治疗; 伴有阴道前壁或阴道后壁脱垂; 排除子宫脱垂伴随严重的心、脑、肾等严重并发症者; 子宫脱垂伴有盆底肌萎缩者; 子宫脱垂伴严重宫颈口溃疡、感染化脓及先天性宫颈延长者。All the selected patients were diagnosed for the first time without formal treatment; accompanied by anterior or posterior vaginal wall prolapse; uterine prolapse accompanied by serious heart, brain, kidney and other serious complications were excluded; uterine prolapse accompanied by pelvic floor Muscular atrophy; uterine prolapse with severe cervical ulcer, infection and suppuration, and congenital elongation of the cervix.
3、治疗方案3. Treatment plan
治疗组:使用本发明中药组合物制成汤剂,早晚各一次,温服,每次200-300ml。Treatment group: use Chinese medicine composition of the present invention to make decoction, each time sooner or later, warm clothes, each 200-300ml.
对照组: 采用支持疗法,包括加强营养,合理安排休息和工作,避免重体力劳动,避免长期站立或下蹲、屏气等增加腹压的动作,保持大便通畅,保持会阴部清洁,积极进行体操运动以锻炼骨盆底肌肉及腹壁肌肉。如嘱咐患者行收缩肛门运动,即肛门一缩一松动作,每日2次,每次10分钟;行膝胸卧位练习:排空小便,放松腰带,全身放松,跪在硬板床上,头放在床上,脸转向一侧,两臂微曲前伸,臀部抬高和大腿呈直角。早晚各1次,每次10分钟。Control group: adopt supportive therapy, including strengthening nutrition, arrange rest and work reasonably, avoid heavy physical labor, avoid long-term standing or squatting, breath-holding and other actions that increase abdominal pressure, keep stool unobstructed, keep perineum clean, and actively perform gymnastics To exercise the pelvic floor muscles and abdominal wall muscles. For example, instruct the patient to perform anal contraction exercises, that is, anal contraction and loosening movements, twice a day, 10 minutes each time; perform knee-chest position exercises: empty the urine, loosen the belt, relax the whole body, kneel on the hard board bed, head Put on the bed, face turned to one side, arms slightly bent forward, hips raised and thighs at right angles. 1 time in the morning and evening, 10 minutes each time.
治疗组和对照组疗程均为30天,一个疗程后统计疗效。The course of treatment for both the treatment group and the control group was 30 days, and the curative effect was counted after one course of treatment.
4、疗效评定标准4. Evaluating Criteria for Efficacy
治愈: 症状消失,宫颈口位置恢复坐骨棘水平以上;Cure: Symptoms disappear, and the position of the cervix returns to above the level of the ischial spine;
显效: 症状消失,子宫回纳于阴道内,宫颈外口接近坐骨棘水平;Significantly effective: Symptoms disappear, the uterus is retracted into the vagina, and the external opening of the cervix is close to the level of the ischial spine;
有效: 症状较前好转,子宫回纳阴道情况稍有改善;Effective: The symptoms are better than before, and the uterus returns to the vagina slightly improved;
无效: 症状无改善,子宫回纳阴道情况较治疗前无改善。Ineffective: The symptoms did not improve, and the situation of the uterus returning to the vagina did not improve compared with before treatment.
5、统计学处理5. Statistical processing
采用SPSS13.0统计软件,计数资料采用x2检验,等级资料采用Ridit检验。Statistical software SPSS13.0 was used, the x2 test was used for the count data, and the Ridit test was used for the rank data.
按上述治疗方案,口服本发明给出的中药组合物汤剂,由表1可以看出,治疗组痊愈26例,显效18例,有效14例,无效2例,总有效率为96.66%;对照组痊愈10例,显效12例,有效20例,无效18例,总有效率为70%。治疗组与对照组比较,痊愈、无效及总有效率有显著统计学差异。According to the above-mentioned treatment plan, oral Chinese medicine composition decoction that the present invention provides, as can be seen from Table 1, 26 examples of treatment group recovered from illness, 18 examples were markedly effective, 14 examples were effective, 2 examples were invalid, and the total effective rate was 96.66%; In the group, 10 cases were cured, 12 cases were markedly effective, 20 cases were effective, and 18 cases were ineffective. The total effective rate was 70%. Compared with the control group, there are significant statistical differences in recovery, ineffectiveness and total effective rate between the treatment group and the control group.
表1两组临床疗效比较Table 1 Comparison of clinical efficacy between the two groups
与对照组比较,*P<0.05 , **P<0.01Compared with the control group, *P<0.05, **P<0.01
本发明中药组合物经制成其他剂型,在实验中均取得了相同或相近的结果,不再一一列举,防止累述,而且,本申请请求保护的是中药组合物(组合发明),而不在于剂型或制备方法,因此,凡采用本申请中药组合物制成的任一剂型,并用于治疗子宫脱垂的药物,均属于本申请保护的范围。The Chinese medicine composition of the present invention has been made into other dosage forms, and the same or similar results have been obtained in the experiment, so they are not listed one by one to prevent repeated descriptions. Moreover, what the application claims is the Chinese medicine composition (combined invention), and It does not depend on the dosage form or the preparation method. Therefore, any medicine made from the traditional Chinese medicine composition of the application and used for the treatment of uterine prolapse belongs to the scope of protection of the application.
6、结论6 Conclusion
本发明组份科学,原料丰富,价格低廉,合理配伍,互相支持,诸药共奏补中益气升提、培元固涩之功效,有效用于治疗子宫脱垂,疗效好,用药安全,有效率高达96%以上,是治疗子宫脱垂药物上的一大创新,具有实际的临床意义。The composition of the invention is scientific, the raw materials are abundant, the price is low, the compatibility is reasonable, and mutual support is achieved. The effective rate is as high as 96%, which is a major innovation in the treatment of uterine prolapse and has practical clinical significance.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510160006.XA CN104771627B (en) | 2015-04-07 | 2015-04-07 | A kind of Chinese medicine composition for treating the prolapse of uterus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510160006.XA CN104771627B (en) | 2015-04-07 | 2015-04-07 | A kind of Chinese medicine composition for treating the prolapse of uterus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104771627A CN104771627A (en) | 2015-07-15 |
| CN104771627B true CN104771627B (en) | 2018-02-13 |
Family
ID=53613609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510160006.XA Expired - Fee Related CN104771627B (en) | 2015-04-07 | 2015-04-07 | A kind of Chinese medicine composition for treating the prolapse of uterus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104771627B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853782A (en) * | 2016-04-12 | 2016-08-17 | 汤华淑 | Traditional Chinese medicinal composition for treating uterine prolapsed |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552531A (en) * | 2012-03-10 | 2012-07-11 | 李承平 | Medicinal composition for tonifying qi and ascending descending qi |
| CN102940716A (en) * | 2012-11-05 | 2013-02-27 | 杜秀兰 | Traditional Chinese medicine for treatment of uterine prolapse |
| CN102961554A (en) * | 2012-11-14 | 2013-03-13 | 凤台县中医院 | Traditional Chinese medicine composition for treating uterine prolapse |
| CN103099993A (en) * | 2013-01-22 | 2013-05-15 | 夏景香 | Traditional Chinese medicine combination for treating uterine prolapse |
-
2015
- 2015-04-07 CN CN201510160006.XA patent/CN104771627B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552531A (en) * | 2012-03-10 | 2012-07-11 | 李承平 | Medicinal composition for tonifying qi and ascending descending qi |
| CN102940716A (en) * | 2012-11-05 | 2013-02-27 | 杜秀兰 | Traditional Chinese medicine for treatment of uterine prolapse |
| CN102961554A (en) * | 2012-11-14 | 2013-03-13 | 凤台县中医院 | Traditional Chinese medicine composition for treating uterine prolapse |
| CN103099993A (en) * | 2013-01-22 | 2013-05-15 | 夏景香 | Traditional Chinese medicine combination for treating uterine prolapse |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853782A (en) * | 2016-04-12 | 2016-08-17 | 汤华淑 | Traditional Chinese medicinal composition for treating uterine prolapsed |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104771627A (en) | 2015-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102151325B (en) | Traditional Chinese medicine for treating breast diseases | |
| CN101700393A (en) | Traditional Chinese medicine composition for treating breast cancer | |
| CN103750024B (en) | Feed for treating urinary retention of sow and preparation method of feed | |
| CN104758607B (en) | A kind of Chinese medicine composition for treating premature ovarian failure | |
| CN105125807A (en) | Traditional Chinese medicine combination for treating adolescent polycystic ovary syndromes | |
| CN102512574B (en) | Traditional Chinese medicine composition for treating animal rickets, its preparation method and its application | |
| CN104771627B (en) | A kind of Chinese medicine composition for treating the prolapse of uterus | |
| CN102988946A (en) | Traditional Chinese medicine composition for treating pantalgia after childbirth | |
| CN103908511B (en) | One treats chondromatous Chinese medicinal pill and preparation method | |
| CN104740571A (en) | Traditional Chinese medicine pills for post-abortion conditioning and preparation method thereof | |
| CN104524494A (en) | Traditional Chinese medicine composition | |
| CN103735849B (en) | A kind of medicine and preparation method for the treatment of hysteromyoma | |
| CN104771679B (en) | A kind of Chinese medicine for treating the prolapse of uterus | |
| CN102580032B (en) | Chinese medicinal composition tablets, powder and oral liquid with effect of promoting urinary calculus removal and preparation method thereof | |
| CN104547733A (en) | Traditional Chinese medicine for reducing leucorrhea | |
| CN105168522A (en) | Medicament for treating abdominal distension and preparation method thereof | |
| CN104436078A (en) | Chinese medicine prescription for treating renal calculus | |
| CN103494991B (en) | Traditional Chinese medicine preparation for treating female metrorrhagia and preparation method thereof | |
| CN104027700A (en) | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method thereof | |
| CN103977279A (en) | Traditional Chinese medicine additive for treating sow hysteritis and preparation method thereof | |
| CN105363005A (en) | Kadsura root-bark traditional Chinese medicinal wine | |
| CN102552758B (en) | Decoction containing Semen plantaginis, Philippine Violet Herb and Chinese lobelia for chronic pelvic inflammatory disease | |
| CN104027686A (en) | Medicine composition for treating virus hepatitis of ducklings | |
| CN1315529C (en) | Foot underside plaster for keeping fitness | |
| CN105497404A (en) | Oral metrorrhagia treating traditional Chinese medicine decoction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180213 Termination date: 20190407 |